Mometa Allergiespray Bei Heuschnupfen (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometa Allergiespray Bei Heuschnupfen, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal hay fever, by reducing nasal inflammation in affected individuals.

GNH USA supplies Mometa Allergiespray Bei Heuschnupfen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages associated with allergic reactions.

- Allergic rhinitis (hay fever): Reduces nasal congestion, itching and sneezing caused by seasonal allergens. - Seasonal allergic rhinitis: Controls symptoms during pollen seasons by decreasing mucosal inflammation. - Allergic nasal symptoms: Provides overall relief of nasal inflammation and discharge linked to allergy triggers.

Adverse reactions may occur with use of mometasone furoate nasal spray.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Throat irritation - Cough - Altered taste or odor perception

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Visual disturbances or cataract formation - Signs of adrenal suppression (e.g., fatigue, hypotension) - Opportunistic fungal infection of the nasal passages

Before using Mometa Allergiespray, consider the following precautions.

- Pregnancy: Consult a healthcare provider to weigh potential benefits against risks. - Children: Safety and appropriate dosing should be determined by a physician. - Concurrent infections: Use with caution if a nasal or systemic infection is present. - Surgery: May need to discontinue before nasal or ear surgery as advised by the surgeon. - Long‑term use: Monitor for signs of adrenal suppression or local tissue changes. - Store at room temperature: Keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medicines.

Major Interactions (Avoid): - Systemic corticosteroids: May increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): May raise local exposure. - Live vaccines: May reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: Additive sedation is unlikely but monitor patient response. - Nasal decongestants: May increase local irritation. - Moderate CYP3A4 inhibitors (e.g., erythromycin): May modestly increase mometasone levels.